Deutsche Übersetzung und Validierung der Checkliste zur Erfassung neuropsychiatrischer Störungen bei Parkinsonerkrankung (CENS-PE)

Zusammenfassung

Ziel der Studie: Validierung der deutschsprachigen Version der Checkliste zur Erfassung neuropsychiatrischer Symptome bei der Parkinsonerkrankung (CENS-PE) von Martínez-Martín et al. (2012).

Methodik: Die CENS-PE wurde an insgesamt 96 Patienten mit Parkinsonerkrankung (PE) (Alter: 65,3 Jahre ± 9,6, 29 Frauen) evaluiert. Die Checkliste umfasst 12 Items, die in die drei Domänen psychotische Symptome, Stimmung/Apathie und Störung der Impulskontrolle unterteilt sind. In mehreren statistischen Analysen wurde die Item- und Reliabilitätsanalyse durchgeführt und die Validität überprüft.

Ergebnisse: Die untersuchten Patienten mit PE wiesen leichte neuropsychiatrische Symptome auf. Die drei Domänen konnten mit der Hauptkomponentenanalyse identifiziert werden. Die Items der Stimmung/Apathie-Domäne erwiesen sich als homogen und trennscharf, die interne Konsistenz war akzeptabel. Für die Domänen psychotische Symptome und Störung der Impulskontrolle waren die Kennwerte nur teilweise ausreichend. Die Checkliste erwies sich als konvergenz-, diskriminanz- und konstruktvalide.

Schlussfolgerung: Die deutsche Übersetzung der CENS-PE ist gesamthaft hinreichend reliabel und valide, um im deutschen Sprachraum eingesetzt zu werden. Die Domänen psychotische Symptome und Störung der Impulskontrolle können aufgrund der geringen Anzahl gemessener Symptome in diesem Bereich nur limitiert beurteilt werden.

Abstract

Objective: The aim of the present study was to validate and provide a German version of the Scale for Evaluation of Neuropsychiatric Disorders in Parkinson’s disease (SEND-PD) of Martínez-Martín et al. (2012).

Method: The German version of the SEND-PD was evaluated in a sample consisting of 96 patients with Parkinson’s disease (PD) (mean age: 65.3 years ± 9.6, 29 female). This scale includes 12 items, representing the domains psychotic symptoms, mood/apathy and impulse control disorders. Reliability and validity analyses were conducted.

Results: The examined patients presented a few neuropsychiatric symptoms. Explorative factor analyses identified the proposed three dimensions solution. The items of the mood/apathy domain were homogenous and selective, and the domain showed acceptable internal consistency. For the other two domains, the values were only partially acceptable. Convergent, discriminate and construct validity were shown.

Conclusion: The German version of the SEND-PD is sufficiently reliable and valid to be adopted in German speaking countries. However, since patients showed only a few symptoms in the dimensions of psychotic symptoms and impulse control disorders, these two domains can be evaluated only to a limited extent.

Schlüsselwörter

Neuropsychiatrische Symptome - Checkliste - Apathie - Angst - Depression - Parkinsonkrankheit

Key words

neuropsychiatric symptoms - checklist - apathy - depression - anxiety - Parkinson’s disease

• Literatur

• 1 Zis P, Martínez-Martín P, Sauerbier A et al. Non-motor symptoms burden in treated and untreated early Parkinson’s disease patients: argument for non-motor subtypes. Eur J Neurol Off J Eur Fed Neurol Soc 2015;
• 2 Chaudhuri KR, Odin P, Antonini A et al. Parkinson’s disease: The non-motor issues. Parkinsonism Relat Disord 2011; 17 (10) 717-723
• 3 Weintraub D. Neuropsychiatric Symptoms in Parkinson Disease and Dementia with Lewy Bodies: What Geriatric Psychiatry Can Learn. Am J Geriatr Psychiatry 2013; 21 (06) 497-500
• 4 Martínez-Martín P, Rodriguez-Blazquez C, Kurtis MM et al. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Mov Disord 2011; 26 (03) 399-406
• 5 Aarsland D, Taylor JP, Weintraub D. Psychiatric issues in cognitive impairment. Mov Disord 2014; 29 (05) 651-662
• 6 Witt K, Daniels C, Reiff J et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol 2008; 7 (07) 605-614
• 7 Appleby BS, Duggan PS, Regenberg A et al. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A meta-analysis of ten years’ experience. Mov Disord 2007; 22 (12) 1722-1728
• 8 Kaufer DI, Cummings JL, Ketchel P et al. Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000; 12 (02) 233-239
• 9 Hautzinger M, Bailer M. Allgemeine Depressionsskala (ADS). Die deutsche Versions des CES-D. Weinheim (Germany): Belz-Verlag; 1991
• 10 Storch PDA, Odin P, Trender-Gerhard I et al. Non-motor Symptoms Questionnaire und Scale für das idiopathische Parkinson-Syndrom. Nervenarzt 2010; 81 (08) 980-985
• 11 Visser M, Verbaan D, van Rooden SM et al. Assessment of psychiatric complications in Parkinson’s disease: The SCOPA-PC. Mov Disord 2007; 22 (15) 2221-2228
• 12 Brown RG, Dittner A, Findley L et al. The Parkinson fatigue scale. Parkinsonism Relat Disord 2005; 11 (01) 49-55
• 13 Martínez-Martín P, Frades-Payo B, Agüera-Ortiz L et al. A short scale for evaluation of neuropsychiatric disorders in Parkinson’s disease: first psychometric approach. J Neurol 2012; 259 (11) 2299-2308
• 14 Lueken U, Seidl U, Schwarz M et al. Psychometric properties of a German version of the Apathy Evaluation Scale. Fortschr Neurol Psychiatr 2006; 74 (12) 714-722
• 15 Fahn S, Marsden CD, Calne DB et al. Unified Parkinson’s disease Scale- UPDRS. in Recent Developments in Parkinson’s disease. 2. Aufl. Florham Park, NJ: Macmillan Health Care Information; 1987: 153–163-293–304
• 16 Ehlers A, Margraf J. Deutschsprachige Adaptation des Beck Anxiety Inventory von AT Beck und RA Stern. Hogrefe Verlagsgruppe; 2007
• 17 Nasreddine ZS, Phillips NA, Bédirian V et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. J Am Geriatr Soc 2005; 53 (04) 695-699
• 18 Zimmermann R, Gschwandtner U, Benz N et al. Cognitive training in Parkinson disease: Cognition-specific vs nonspecific computer training. Neurol 2014; 82 (14) 1219-1226
• 19 Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988; 51 (06) 745-752
• 20 van der Linden FAH, Kragt JJ, Klein M et al. Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use. J Neurol Neurosurg Psychiatry 2005; 76 (12) 1677-1681
• 21 Briggs SR, Cheek JM. The role of factor analysis in the development and evaluation of personality scales. J Pers 1986; 54 (01) 106-148
• 22 R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2012
• 23 Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. JR Stat Soc Ser B Methodol 1995; 57 (01) 289-300
• 24 Litvan I, Goldman JG, Tröster AI et al. Diagnostic criteria for mild cognitive impairment in Parkinson`s disease: Movement Disorder Society Task guidelines. Mov Disord Soc 2012; [phone]
• 25 Leentjens AFG, Dujardin K, Marsh L et al. Apathy and anhedonia rating scales in Parkinson’s disease: Critique and recommendations. Mov Disord 2008; 23 (14) 2004-2014
• 26 Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 2006; 5 (03) 235-245
• 27 Riedel O, Klotsche J, Spottke A et al. Frequency of dementia, depression, and other neuropsychiatric symptoms in 1449 outpatients with Parkinson’s disease. J Neurol 2010; 257 (07) 1073-1082
• 28 Barone P, Antonini A, Colosimo C et al. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 2009; 24 (11) 1641-1649
• 29 Shulman LM, Taback RL, Bean J et al. Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord 2001; 16 (03) 507-510
• 30 Rodriguez-Violante M, Cervantes-Arriaga A, Velazquez-Osuna S et al. Independent Validation of the SEND-PD and Correlation with the MDS-UPDRS Part IA, Independent Validation of the SEND-PD and Correlation with the MDS-UPDRS Part IA. Park Dis Park Dis 2014; 2014 (2014) e260485
• 31 Marin RS. Apathy: A neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991; 3 (03) 243-254
• 32 Leentjens AFG, Dujardin K, Marsh L et al. Anxiety rating scales in Parkinson’s disease: critique and recommendations. Mov Disord Off J Mov Disord Soc 2008; 23 (14) 2015-2025